OFD 2022

Program

Note: Program is subject to change. 

To view session descriptions click on "More Info" and then click on the presenter's name to view their biography.

Saturday
October 22, 2022
All times indicated are Eastern Daylight Times (EDT).

Welcoming Remarks
Introduction to Radiation Oncology
Presenters
Brock Debenham
Photo of Brock Debenham
Photo of Brock Debenham
Brock Debenham
MD, FRCPC, DABR
Assistant Dean, Academic Affairs, MD Program, University of Alberta — Edmonton, Alberta

Dr. Debenham completed his medical degree and residency at the University of Alberta, followed by a fellowship in brachytherapy and intraoperative radiotherapy at Mount Sinai Beth Israel in New York.  He was program director of the radiation oncology residency program from 2014-2021, and currently serves as an assistant dean in the MD program.  He specializes in the treatment of head and neck malignancies.

Brock Debenham
University of Alberta, Edmonton, Alberta

Presentation Summary

A basic overview of radiation oncology, including how radiation therapy works, the different types of radiotherapy used in cancer patients, the logistics of treatment, and how treatment has evolved over the years.

Learning Objectives

  1. A participant will be able to understand the mechanism of action for radiotherapy treatment.
  2. A participant will be able to describe the common types of radiotherapy and how they are delivered to patients.
  3. A participant will be able to describe the roles of curative and palliative radiotherapy in cancer patients.
The Role of Pharmacy Technicians in Clinical Trials
Presenters
Kathy LeBreux
Photo of Kathy LeBreux
Photo of Kathy LeBreux
Kathy LeBreux
Registered Pharmacy Research Technician, Clinical Trials, Ottawa Hospital Cancer Centre — Cumberland, Ontario

Kathy LeBreux is a Registered Pharmacy Technician (RPhT) working at the Ottawa Hospital Cancer Centre.  She is part of the Pharmacy Clinical Trials Research Team that works together to provide Investigational Medication to their patients.  Before her work in research, Kathy was the Team Leader of the Inpatient Oncology Satellite Pharmacy and prior to that the Pharmacy Distribution Supervisor, both at the Ottawa Hospital.  Earlier in her career, she gained experience working as a Pharmacy Technician at the National Defense Medical Centre and the Royal Ottawa Hospital.


Kathy will provide information about her day-to-day work with the Clinical Trials Team at the Cancer Centre.  She hopes that conference attendees will be interested in the topic of her talk and that it sparks many questions following her presentation.   
 

Kathy LeBreux
Ottawa Hospital Cancer Centre, Cumberland, Ontario

Presentation Summary

Pharmacy Technicians working in clinical trials is a well established practice at the Ottawa Hospital Cancer Centre, however, in many other centres this role may not exist.
During this presentation I will provide information and details about this exciting position and how it is conducted within the scope of a Pharmacy Technician.  One of this presentation’s goals is that Pharmacy Technicians and their employers can take this information back to their workplaces and expand the role of Pharmacy Technicians working in their own Pharmacy Departments.
 

Learning Objectives

  1. Describe the history behind the role of Pharmacy Technicians working in clinical trials
  2. Explore the wide variety of tasks involved with clinical trials
  3. Identify the skills required to effectively perform as a Pharmacy Technician in clinical trials
  4. Outline the challenges involved with a Pharmacy Technician clinical trials role
Satellite symposium
Novartis Sponsored Symposium - CDK4/6 Inhibitors for HR+ HER2- Advanced Breast Cancer: What’s New and What Does It Mean for You
Presenters
Thomas McFarlane
Sudha Rajagopal
Photo of Thomas McFarlane
Photo of Thomas McFarlane
Thomas McFarlane
Clinical Lecturer/Researcher, Pharmacy, University of Waterloo — Kitchener, Ontario
Tom is currently a Clinical Lecturer and a researcher at the University of Waterloo School of Pharmacy in Kitchener, Ontario, where he created, coordinates, and teaches the oncology portion of the curriculum in the Doctor of Pharmacy program and conducts practice based research.
Thomas McFarlane
University of Waterloo, Kitchener, Ontario
Photo of Sudha Rajagopal
Photo of Sudha Rajagopal
Sudha Rajagopal
Medical Oncologist , Trillium Health Partners Credit Valley Hospital

She is a medical oncologist at the Trillium Health Partners Credit Valley Hospital and has been in clinical practice for 30 years.
She did her Internal medicine and medical Oncology training at the University of Toronto.
She treats Breast cancer and melanoma and is the Skin Site lead at the THP.
She also teaches within the University of Toronto Medical Oncology Training Programme working with residents and junior trainees,
She is involved in clinical research in breast cancer and melanoma and sits on the Cancer Care Ontario melanoma Guidelines committee, the Canadian Clinical Trials Group metastatic Melanoma and IND working group as well as the Canadian Melanoma Research Network.
 

Sudha Rajagopal
Trillium Health Partners Credit Valley Hospital

Moderator: Scott Edwards, Clinical Oncology Pharmacist Specialist, Dr H Bliss Murphy Cancer Center, Memorial University, Newfoundland and Labrador

Presentation Summary 

There have been a lot of practice-changing data released recently for the management of patients with HR+ HER2- advanced breast cancer. Join us for a dynamic panel discussion, during which moderator Dr. Scott Edwards, and speakers Dr. Sudha Rajagopal and Dr. Tom McFarlane review the latest CDK4/6 inhibitor data and what the latest developments mean for your practice. 

Learning Objectives: 

  1. Review the latest clinical evidence for HR+ HER2- metastatic breast cancer patients 
  2. Discuss the practical implication of this latest evidence for pharmacist 
  3. Provide case-based best practices for optimizing patient care within the pharmacy
Lunch Break
Diversity, Equity and Inclusion in Cancer Care
Presenters
Frances Folkman
Photo of Frances Folkman
Photo of Frances Folkman
Frances Folkman
Pharmacy Clinical Practice Leader Adult Cancer, Tom Baker Cancer Centre — Calgary, Alberta

Frances graduated from the University of Alberta Faculty of Pharmacy in 1993.  She completed a Year 1 pharmacy residency at the Alberta Children’s Hospital in 1994.
Frances is a Pharmacy Clinical Practice Leader who has worked at the Tom Baker Cancer Centre in Calgary, Alberta since 2002.  Her clinical practice is in ambulatory neuro oncology.  She is also the residency coordinator for the Alberta Health Services (AHS) Cancer Care pharmacy residency program. 
In the area of diversity and inclusion, Frances has been a member of a Clinical Practice Leader anti-racism committee since 2020. She has facilitated diversity and inclusion discussions provincially with the AHS pharmacy residents for 2 years.
 

Frances Folkman
Tom Baker Cancer Centre, Calgary, Alberta

Presentation Summary 

Oncology pharmacists and pharmacy technicians collaborate with patients and members of the healthcare team who have a wide variety of visible and invisible diverse traits.  Understanding diversity and demonstrating inclusive behaviour is essential in developing trusting, effective communication and relationships.
This presentation will allow oncology pharmacy team members to gain an understanding of the multidimensional factors of diversity and the impact of developing inclusive behaviour.  Elements of diversity and inclusion including bias, allyship and antiracism will be discussed.

Learning Objectives

  1. To describe the negative impacts of unconscious bias and lack of inclusion on patients and peers.
  2. To identify strategies to open lines of communication and gain trusting relationships with patients and peers with diverse traits.
  3. To be inspired to learn more about diversity and inclusion and positively affect the experiences of patients and peers.
Understanding the Different Types of Lymphoma
Presenters
Megan Munden
Photo of Megan Munden
Photo of Megan Munden
Megan Munden

Megan Munden received her Bachelor of Science in Pharmacy from Memorial University School of Pharmacy in 2016, and after spending 4 short months as a relief community pharmacist she started her career as a hospital pharmacist, ultimately landing as an oncology pharmacist in 2018. Since 2018 she has been working in the Acute Care Adult Hematology/Oncology setting, along with the NL Cellular Therapy and Transplant Program. Megan has been a part of the care team for both benign and malignant hematology, with a special interest in acute malignant disease management and cellular therapy. While working in acute care Megan has been involved in treating many types of malignant hematologic disorders, including a multitude of lymphomas, relapsed and resistant lymphomas, transformed lymphomas as well as treatment related

Megan Munden

Presentation Summary 

Throughout this presentation, listeners will gain a high level understanding of the different types of lymphomas, including Hodgkin and Non-Hodgkin lymphoma and subtypes. The presentation will explore lymphoma diagnosis and management, include basic pathology findings, symptoms, common treatment options and current clinical challenges.

Learning Objectives

  1. Define lymphoma 
  2. Differentiate between Hodgkin lymphoma (HL) and Non-Hodgkin lymphoma (NHL) 
  3. Understand clinical features of and subtypes of HL& NHL 
  4. Explain the first line management of common subtypes of both HL & NHL
Chemotherapy Admixtures: near misses and how we avoid them
Presenters
Ryan Lethbridge
Photo of Ryan Lethbridge
Photo of Ryan Lethbridge
Ryan Lethbridge

Graduated Top of my class with a Pharmacy Technician Diploma from Compu-College in 2007. I later completed the Registered Pharmacy Technician (RPT) bridging program through Humber College and Selkirk College. I became licensed as a Registered Pharmacy Technician in Newfoundland and Labrador in 2017. I have worked for a short period of time with Central health in Grandfalls-Winsor NL, then since 2008 with Eastern Health in St. John’s NL. For the past 10 years my specialty area has been Sterile Hazardous Admixtures or Chemotherapy Preparation. I have been involved heavily in LEAN initiatives over the years, NAPRA policy implementation, and working on the design and implementation of a new Pharmacy Chemotherapy Suite at the Dr. H Bliss Murphy Center in St. John’s, NL. I have also recently begun a role of a Drug Access Navigator at the Dr. H Bliss Murphy Cancer Center, and work with Medical Oncology and Radiation Oncology. 

Ryan Lethbridge

Presentation Summary

This discussion will provide an overview on the history of our Hospital Pharmacy chemotherapy processes, and the steps we have taken over the years to mitigate near misses in chemotherapy preparation.

Learning Objectives

  1. Describe the workflow involved in chemotherapy preparation and how it can contribute to near misses
  2. Discuss how computers and technology can have an impact on near misses 
  3. Identify human factors that can relate to chemotherapy preparation near misses 
Crossing the Blood Brain Barrier: Intrathecal Chemotherapy
Presenters
Chris Tse
Melissa Lo
Photo of Chris Tse
Photo of Chris Tse
Chris Tse
Pharmacist, University Health Network — Toronto, Ontario

Chris Tse is an oncology pharmacist working at Princess Margaret Hospital in the autologous stem cell transplant unit. Chris completed his hospital residency specializing in oncology in 2022, where he completed rotations in malignant hematology, allogeneic stem cell transplant, and solid tumours. Chris hosts two pharmacy-related podcasts, the CAPhO Connections Podcast and Off the Script Podcast.

Chris Tse
University Health Network , Toronto, Ontario
Photo of Melissa Lo
Photo of Melissa Lo
Melissa Lo
Investigational Pharmacy Services Pharmacist/Clinical Pharmacist in Malignant Hematology and transplant, Pharmacy, University Health Network- Princess Margaret Hospital — Toronto, Ontario

Melissa received her PharmD from University of the Sciences in Philadelphia in 2011 and went on to complete an Ambulatory Pharmacy Practice Residency at Sunnybrook Health Sciences Centre in 2012. Shortly after, she joined the ambulatory pharmacy team at Princess Margaret Cancer Centre where she has been practicing for the past 7 years and more recently is splitting her time in the malignant hematology day unit . She has participated in a variety of educational roles and quality improvement projects. She was part of the pilot project exploring the role of a pharmacist in an interdisciplinary outpatient malignant hematology clinic and most recently completing a secondment with Investigational Pharmacy Services.

Melissa Lo
University Health Network- Princess Margaret Hospital, Toronto, Ontario

Presentation Summary

Melissa Lo and Christopher Tse will present a pharmacist-tailored overview of intrathecal chemotherapy. The presentation will briefly review the physiology and pharmacokinetic implications of the blood brain barrier before diving into the indications, pharmacology, preparation, administration, and complications of intrathecal chemotherapy. Specific questions which will be addressed include: What is the role of intrathecal chemotherapy in treatment of cancer? How is intrathecal chemotherapy properly prepared? What are the different methods of administering intrathecal chemotherapy? How does one choose between different chemotherapy agents for intrathecal use?

Learning Objectives

  1. Review physiology and pharmacokinetic implications of the blood brain barrier.
  2. Understand which medical conditions require intrathecal chemotherapy for treatment.
  3. Evaluate the proceed parameters required to administer intrathecal chemotherapy.
  4. Distinguish between different chemotherapeutic agents used in intrathecal chemotherapy.
  5. Understand the treatment of complications related to intrathecal chemotherapy.
Satellite symposium
AstraZeneca Sponsored Symposium – Applying Practical Strategies for the Treatment and Management of Patients with CLL
Presenters
Tina Crosbie
Raymond Vles
Photo of Tina Crosbie
Photo of Tina Crosbie
Tina Crosbie
Clinical Pharmacist - Hematology, Pharmacy, CAPhO Past-President — Ottawa, Ontario
Tina is the clinical pharmacist in the hematology chemotherapy unit at The Ottawa Hospital. Here she oversees patients with lymphomas, multiple myeloma and chronic lymphocytic leukemia who are receiving care on an outpatient basis. Tina joined the hematology team at The Ottawa Hospital in 1999. Tina has written educational materials and has given presentations on topics in hematology and patient care. She enjoys being a peer reviewer for CCCEP, is Past President of CAPhO and serves on the Oncology Fundamental Day (OFD) education committee. Tina was honoured to chair the 2018 CAPhO conference in Ottawa. Tina received her Bachelor of Science in Pharmacy at Memorial University of Newfoundland and completed an accredited residency in hospital pharmacy in Ottawa.
Tina Crosbie
CAPhO Past-President, Ottawa, Ontario
Photo of Raymond Vles
Photo of Raymond Vles
Raymond Vles
Chair, CLL Canada — Montreal, Quebec

Raymond Vles is Board Chair of CLL Canada, a volunteer organization of patients and caregivers, as well as facilitator of the Montreal CLL Support Group. 
As Boar Chair, Raymond Vles acts as spokesperson for CLL Canada. He has made presentations on the CLL patient experience to a number of organizations, including the Oncology Nurses of Ontario, the Canadian CLL Research meeting, the CLL Horizons conference of the CLL Advocates Network and to a number of pharmaceutical companies. 
He retired in May 2020 after 17 years working for the City of Montreal in various capacities, including Information System Pilot, Change management Consultant and Internal Organizational Development Consultant. 
Prior to working for the City, he spent 15 years as an independent consultant and group facilitator, assisting clients in the public and private sector in the management of environmental and other public policy issues. He facilitated numerous stakeholder consultations, primarily but not exclusively on environmental issues.  He also advised clients on stakeholder relations and environmental policy.  
Other professional experiences include 5 years as executive director of an environmental NGO, a year as a Parliamentary Intern in Ottawa and 2 years working in a manufacturing company. 
Raymond Vles holds a Master’s degree in Organizational Development as well as a Bachelor’s degree and Master’s degree in Environmental Studies. He lives in Montreal and is fluent in spoken and written English and French. 
In addition to his involvement on the CLL Canada board of directors, Raymond Vles is a board member, Jazzworks Canada.  He was previously a member and President  of the board of directors of CAMMAC (Musicien amateurs du Canada Canadian Amateur Musicians).
While employed at the City of Montreal, he was volunteer Campaign Director for Centraide (United Way) in his workplace.  Previous to that he was a volunteer member of an allocation committee and of the Social Development Investment Committee, Centraide (United Way). 
Raymond has two adult children and lives with his spouse in Montreal, Canada. 
 

Raymond Vles
CLL Canada, Montreal, Quebec

Moderator: Carla Pensack, Oncology Pharmacist, Cancer Care Manitoba

Presentation Summary 

CLL may be viewed as a chronic disease; a chronic cancer where the goal is to control it by using lifelong surveillance and therapy.
During this symposium we will ask the question, “What would you do next?” in your approach with patients. Besides recognizing drug interactions with CLL treatments, attendees will also incorporate disease interactions as part of their pharmacy monitoring plan.
 

Learning Objectives

By attending the symposium today, attendees will be able to:

  1. Use case examples to review the choices available to treat CLL and recognize how that choice is made by patient and prescriber. 
  2. Develop a pharmacy care plan to support patients starting therapy for CLL and what may be different about their care plan for a patient already established on a CLL therapy.

Sunday
October 23, 2022
All times indicated are Eastern Daylight Times (EDT).

Drug Interactions Workshop